Abstract
Giriş: Camsı hücreli karsinom, uterin serviksi tutan, agresif gidişli ve görece olarak kötü prognoza sahip, tüm servikal kanserlerin
%1’den azını oluşturan çok nadir bir klinik antitedir. Adenoskuamöz karsinomun bir alt tipi olarak tanımlanmıştır. Özel bir histolojik
görüntüye sahiptir.
Olgu: Biz burada; serviksin glassy hücreli karsinomunu sunduk ve bu tümörün klinik, morfolojik, histokimyasal, immünhistokimyasal
özelliklerini literatür eşliğinde tartıştık.
Sonuç: Bu tümörler daha kötü prognoza sahip olduklarından doğru tanı koymak ve diğer tip cervikal karsinomlardan ayırmak
oldukça önemlidir.
References
- 1. Littman P, Clement P B, Henriksen B, et al. Glassy cell carcinoma of the cervix.Cancer 1976;37 (5):2238-2246
- 2. Pak HY, Yokota S B, Paladugu R R, Agliozzo C M. Glassy cell carcinoma of the cervix, cytologic and clinicopathologic analysis . Cancer 1983; 52 (2) : 307-312
- 3. Hadi R, Kumar M, Pat S, et al. Glassy cell carcinoma (GCC) of uterine cervix. Sri Lanka Journal of Obstetrics and Gynaecology 2011; 33(1): 65-67
- 4. Deshpande AH, Kotwal MN , Bobhate SK. Glassy cell carcinoma of the uterine cervix a rare histology: report of three cases with a review of the literature. Indian J Cancer 2004; 41(2): 92-95.
- 5. Costa MJ, Kenny MB, Hewan-Lowe K, Judd R. Glassy cell features in adenosquamous carcinoma of the uterine cervix. Histologic, ultrastructural, immunohistochemical, and clinical fi ndings. Am J Clin Pathol 1991;96(4):520- 528.
- 6. Ukita Y, subamoto HT, Kato T, Suno S, Shibahara H. A case of primary metastatic glassy cell carcinoma of the uterine cervix that responded to combined docetaxel and carboplatin. Gynecologic Oncology Reports 2013;6: 19–21
- 7. Nagai T, Okubo T , Sakaguchi R, Seki H, Takeda S. Glassy cell carcinoma of the uterine cervix responsive to neoadjuvant intraarterial chemotherapy. Int J Clin Oncol 2008; 13(6): 541–544
- 8. Gray HJ, Garcia R, Tamimi HK, et al. Glassy cell carcinoma of the cervix revisited. Gynecol Oncol 2002;85(2):274- 277.
Abstract
Introduction: Glassy cell carcinoma is a very rare clinical entitiy involving uterine cervix, comprising <1% of all cervical cancers
with aggressive course and relatively poor prognosis. It was defined as a subgroup of cervical adenosquamous carcinoma. Its
histologic appearance is distinctive.
Case: We presented a case of glassy cell carcinoma of the cervix and discussed the clinical, morphological, histochemical and immunohistochemical
characteristics of this tumor with the review of the literature.
Conclusion: Because this group tumors prognosis has been poor, it was very important to be made to correctly identify and distinguish
these tumors from other types of cervical carsinomas
References
- 1. Littman P, Clement P B, Henriksen B, et al. Glassy cell carcinoma of the cervix.Cancer 1976;37 (5):2238-2246
- 2. Pak HY, Yokota S B, Paladugu R R, Agliozzo C M. Glassy cell carcinoma of the cervix, cytologic and clinicopathologic analysis . Cancer 1983; 52 (2) : 307-312
- 3. Hadi R, Kumar M, Pat S, et al. Glassy cell carcinoma (GCC) of uterine cervix. Sri Lanka Journal of Obstetrics and Gynaecology 2011; 33(1): 65-67
- 4. Deshpande AH, Kotwal MN , Bobhate SK. Glassy cell carcinoma of the uterine cervix a rare histology: report of three cases with a review of the literature. Indian J Cancer 2004; 41(2): 92-95.
- 5. Costa MJ, Kenny MB, Hewan-Lowe K, Judd R. Glassy cell features in adenosquamous carcinoma of the uterine cervix. Histologic, ultrastructural, immunohistochemical, and clinical fi ndings. Am J Clin Pathol 1991;96(4):520- 528.
- 6. Ukita Y, subamoto HT, Kato T, Suno S, Shibahara H. A case of primary metastatic glassy cell carcinoma of the uterine cervix that responded to combined docetaxel and carboplatin. Gynecologic Oncology Reports 2013;6: 19–21
- 7. Nagai T, Okubo T , Sakaguchi R, Seki H, Takeda S. Glassy cell carcinoma of the uterine cervix responsive to neoadjuvant intraarterial chemotherapy. Int J Clin Oncol 2008; 13(6): 541–544
- 8. Gray HJ, Garcia R, Tamimi HK, et al. Glassy cell carcinoma of the cervix revisited. Gynecol Oncol 2002;85(2):274- 277.
Details
| Other ID | JA36VN59CK |
|---|---|
| Journal Section | Case Report |
| Authors | |
| Publication Date | July 1, 2014 |
| Submission Date | July 1, 2014 |
| Published in Issue | Year 2014 Volume: 17 Issue: 3 |